Abiogen Pharma Completes the Acquisition of Effrx

PISA, Italy, May 29, 2023 -- (Healthcare Sales & Marketing Network) -- Abiogen Pharma S.p.A., Italian leading company in the field of osteoarticular and bone metabolism diseases, is pleased to announce the acquisition of a 97,09% stake in EffRx Pharmaceut... Biopharmaceuticals, Mergers & Acquisitions Abiogen Pharma, EffRx Pharmaceuticals, alendronate, osteoporosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news